Metabotropic glutamate receptor agonists for schizophrenia
- PMID: 18245019
- DOI: 10.1192/bjp.bp.107.045088
Metabotropic glutamate receptor agonists for schizophrenia
Erratum in
- Br J Psychiatry. 2008 Mar;192(3):234
Abstract
A drug acting at metabotropic glutamate receptors has recently been reported to be an effective antipsychotic, breaking the rule that only dopamine receptor-blocking drugs have this property. The finding complements accumulating evidence that glutamatergic abnormalities are important in the pathophysiology of schizophrenia.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
